Depriving tumours of extracellular glutathione or inhibiting its breakdown is potentially a viable therapeutic strategy for cancer patients, the authors state
Drug-specific variables that may affect half-life Drug formulation (ie, modified or controlled release preparations extend half-life) How the drug behaves in the body (ie, zero-order, first-order, or multi-compartmental pharmacokinetics) How the drug is administered (half-life may be different with IV administration, compared to intranasal or oral administration) How the drug is cleared from the body (eg, kidneys, liver, lungs) If the drug accumulates in fat or other types of tissue If the drug binds to proteins or not Presence of metabolites or other drugs that may interact Properties of the drug, including molecule size, charge, and pKa The volume of distribution of a drug Other variables, such as if the drug is actively transported, is self-induced, or has saturation pharmacokinetics
Ch H, Qun 7, TP.HCM cho bit: Mnh dng th 1 hp Dr.Dit v tht s bt ng v da sng hn r rt ch sau 2 tun
The doctor selected Ultherapy Prime for three distinct reasons: Unmatched Precision via Live Imaging Ultherapy Prime features a significantly upgraded, larger screen with zero lag time
Mutluoglu G, Yay T, Glsever AB, Madenci C, Kaptanagasi AO
Zacznik analizy czystoci DSIP w opisie
